These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7846209)

  • 1. Opioid physical dependence development: effects of single versus repeated morphine pretreatments and of subjects' opioid exposure history.
    Azolosa JL; Stitzer ML; Greenwald MK
    Psychopharmacology (Berl); 1994 Feb; 114(1):71-80. PubMed ID: 7846209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid physical dependence development in humans: effect of time between agonist pretreatments.
    Kirby KC; Stitzer ML
    Psychopharmacology (Berl); 1993; 112(4):511-7. PubMed ID: 7871065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain reward deficits accompany naloxone-precipitated withdrawal from acute opioid dependence.
    Liu J; Schulteis G
    Pharmacol Biochem Behav; 2004 Sep; 79(1):101-8. PubMed ID: 15388289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute opioid physical dependence in postaddict humans: naloxone dose effects after brief morphine exposure.
    Heishman SJ; Stitzer ML; Bigelow GE; Liebson IA
    J Pharmacol Exp Ther; 1989 Jan; 248(1):127-34. PubMed ID: 2913267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precipitated opioid withdrawal across acute physical dependence induction methods.
    Compton P; Miotto K; Elashoff D
    Pharmacol Biochem Behav; 2004 Feb; 77(2):263-8. PubMed ID: 14751453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence.
    Schulteis G; Morse AC; Liu J
    Psychopharmacology (Berl); 2004 Oct; 175(4):463-72. PubMed ID: 15083263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute physical dependence in man: effects of naloxone after brief morphine exposure.
    Bickel WK; Stitzer ML; Liebson IA; Bigelow GE
    J Pharmacol Exp Ther; 1988 Jan; 244(1):126-32. PubMed ID: 3335995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated experience with naloxone facilitates acute morphine withdrawal: potential role for conditioning processes in acute opioid dependence.
    Schulteis G; Morse AC; Liu J
    Pharmacol Biochem Behav; 2003 Dec; 76(3-4):493-503. PubMed ID: 14643849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of opioid agonist and antagonist in dams exposed to morphine during the perinatal period.
    Sobor M; Timár J; Riba P; Friedmann T; Király KP; Gyarmati S; Al-Khrasani M; Fürst S
    Brain Res Bull; 2011 Jan; 84(1):53-60. PubMed ID: 20934489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval. I.
    Heishman SJ; Stitzer ML; Bigelow GE; Liebson IA
    J Pharmacol Exp Ther; 1989 Aug; 250(2):485-91. PubMed ID: 2760839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute opioid physical dependence in humans: effect of varying the morphine-naloxone interval II.
    Kirby KC; Stitzer ML; Heishman SJ
    J Pharmacol Exp Ther; 1990 Nov; 255(2):730-7. PubMed ID: 2243350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Butorphanol agonist effects and acute physical dependence in opioid abusers: comparison with morphine.
    Greenwald MK; Stitzer ML
    Drug Alcohol Depend; 1998 Dec; 53(1):17-30. PubMed ID: 10933337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time course of naloxone-precipitated withdrawal after acute methadone exposure in humans.
    Stitzer ML; Wright C; Bigelow GE; June HL; Felch LJ
    Drug Alcohol Depend; 1991 Dec; 29(1):39-46. PubMed ID: 1665778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opiate withdrawal signs precipitated by naloxone following a single exposure to morphine: potentiation with a second morphine exposure.
    Schulteis G; Heyser CJ; Koob GF
    Psychopharmacology (Berl); 1997 Jan; 129(1):56-65. PubMed ID: 9122364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute physical dependence in humans: repeated naloxone-precipitated withdrawal after a single dose of methadone.
    Wright C; Bigelow GE; Stitzer ML; Liebson IA
    Drug Alcohol Depend; 1991 Mar; 27(2):139-48. PubMed ID: 1647293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute opioid physical dependence in humans: effect of naloxone at 6 and 24 hours postmorphine.
    Heishman SJ; Stitzer ML; Bigelow GE; Liebson IA
    Pharmacol Biochem Behav; 1990 Jun; 36(2):393-9. PubMed ID: 2356213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Focal kappa-opioid receptor-mediated dependence and withdrawal in the nucleus paragigantocellularis.
    Sinchaisuk S; Ho IK; Rockhold RW
    Pharmacol Biochem Behav; 2002 Dec; 74(1):241-52. PubMed ID: 12376173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute physical dependence: time course and relation to human plasma morphine concentrations.
    June HL; Stitzer ML; Cone E
    Clin Pharmacol Ther; 1995 Mar; 57(3):270-80. PubMed ID: 7697945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Withdrawal from dependence upon butorphanol uniquely increases kappa(1)-opioid receptor binding in the rat brain.
    Fan LW; Tanaka S; Tien LT; Ma T; Rockhold RW; Ho IK
    Brain Res Bull; 2002 Jun; 58(2):149-60. PubMed ID: 12127012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NMDA antagonist memantine attenuates the expression of opioid physical dependence in humans.
    Bisaga A; Comer SD; Ward AS; Popik P; Kleber HD; Fischman MW
    Psychopharmacology (Berl); 2001 Aug; 157(1):1-10. PubMed ID: 11512037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.